Development and validation of interpretable machine learning model for pre-treatment predicting the response to targeted and immune therapy in hepatocellular carcinoma
European Journal of Radiology · 2025
DOI: 10.1016/j.ejrad.2025.112353 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Radiology, 2025. Verfasst von Runqian Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 51008…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Machine Learning, Tomography, X-Ray Computed. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Project, China National Funds for Distinguished Young Scientists.
Abstract (Originalsprache)
BACKGROUND: Targeted and immune therapies are used for unresectable hepatocellular carcinoma (HCC), but their efficacy is limited by tumor heterogeneity. Identifying patients who will benefit from targeted and immune therapy is crucial for optimizing treatment strategies and prognosis. We aimed to develop and validate interpretable machine learning (ML) models integrating clinical and CT imaging characteristics for pretreatment prediction of objective response and prognosis to targeted and immune therapy in HCC. METHODS: This retrospective multicenter study included 413 patients from two institutions who received targeted and immune therapy. Clinical and CT characteristics were collected. Logistic Regression (LR), Support Vector Machine (SVM), Random Forest (RF), and eXtreme Gradient Boosting (XGBoost) models were developed and validated to predict treatment response and overall survival (OS). Model performance was assessed by area under the curve (AUC) and Kaplan-Meier analysis. Additionally, SHAP (SHapley Additive exPlanations) analysis explained model predictions by aggregating the attribution values for each input feature. RESULTS: The XGBoost model demonstrated the best performance with AUCs of 0.802 (95 % CI: 0.744-0.860) and 0.805 (95 % CI: 0.741-0.868) in training and validation cohorts. Significant predictors included Barcelona Clinic Liver Cancer (BCLC) stage, tumor number, tumor margin, peritumoral enhancement and macrovascular invasion. Kaplan-Meier analysis showed that high-risk scores stratified by XGBoost model were associated with shorter OS (HR: 0.740, 95 % CI: 0.665-0.823, P < 0.001). CONCLUSION: XGBoost model effectively predicted treatment response and prognosis in HCC patients undergoing targeted and immune therapy, offering a noninvasive tool to guide treatment decisions and optimize clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; Guangdong Provincial Key Laboratory of Artificial Intelligen…
- Department of Interventional Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022 Anhui, China. Electronic address: ahsllkc@163.com.
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022 Anhui, China. Electronic address: duobi2004@126.com.
Förderung
- National Natural Science Foundation of China
- Guangzhou Municipal Science and Technology Project
- China National Funds for Distinguished Young Scientists
Zitieren
APA
Huang, R., Liu, K., Yan, L., Liu, Z., Wu, L., Wu, X., & Liang, C. (2025). Development and validation of interpretable machine learning model for pre-treatment predicting the response to targeted and immune therapy in hepatocellular carcinoma. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2025.112353
Vancouver
Huang R, Liu K, Yan L, Liu Z, Wu L, Wu X, et al. Development and validation of interpretable machine learning model for pre-treatment predicting the response to targeted and immune therapy in hepatocellular carcinoma. European Journal of Radiology. 2025. doi:10.1016/j.ejrad.2025.112353
BibTeX
@article{Huang2025,
author = {Huang, Runqian and Liu, Kaicai and Yan, Lifen and Liu, Zaiyi and Wu, Lei and Wu, Xingwang and Liang, Changhong},
title = {Development and validation of interpretable machine learning model for pre-treatment predicting the response to targeted and immune therapy in hepatocellular carcinoma},
journal = {European Journal of Radiology},
year = {2025},
doi = {10.1016/j.ejrad.2025.112353}
}
EUVIMED